Explore /
Poster
/ Co-occurring gene alterations associated with efficacy of osimertinib in EGFR-mutated lung cancer: Based on a large-scale genomic screening project (LC-SCRUM-Asia).

Co-occurring gene alterations associated with efficacy of osimertinib in EGFR-mutated lung cancer: Based on a large-scale genomic screening project (LC-SCRUM-Asia).

Authors

Yuji Shibata

Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan

Yuji Shibata , Shingo Matsumoto , Shunta Mori , Tetsuya Sakai , Hiroki Izumi , Hibiki Udagawa , Kaname Nosaki , Yoshitaka Zenke , Kiyotaka Yoh , Haruko Daga , Atsuhisa Tamura , Jun Sakakibara-Konishi , Shoichi Kuyama , Naoki Furuya , Atsushi Nakamura , Masato Shingyoji , Kazumi Nishino , Terufumi Kato , Susumu Kobayashi , Koichi Goto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 9103)

DOI

10.1200/JCO.2022.40.16_suppl.9103

Abstract #

9103

Poster Bd #

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

$A nation-wide genomic screening project for further development of targeted therapies in treatment-refractory non–small-cell lung cancer (LC-SCRUM-TRY).$